drugset / Trial / NCT07013240

Botulinum Toxin Injection After Sternotomies to Improve Scar Aspect and Impact

NCT07013240

Phase 3 Not yet recruiting 50 enrolled University Hospital, Bordeaux
RandomizedParallel-groupQuadruple-blindPrevention

Summary

Sternotomy scars, which are localized in a high-tension area are often dystrophic, hypertrophic or keloidal, and can be difficult to accept to patients who already endured a heavy intervention with high psychologic impact. The investigators wish to evaluate immediate post-surgical injection of botulinum toxin to improve scar aspect and impact. A randomized, placebo-controlled, split-scar clinical trial will determine the improvement of scar aspects assessed by standardized scores (SBSES, POSAS), patient satisfaction and tolerance.

Timeline

Start
2025-07-05
Primary completion
2027-02-28
Completion
2027-02-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum toxin type A Protein / enzyme biologic 50 iu Other

Indications

No indication recorded.